of the potential of immune system-derived miRNAs to revolutionize CVD management and therapy, addressing a major

with immune checkpoint inhibitors (median(IQR) 0.85(0.55–1.03) vs. 0.48(0.15–0.68) before and after therapy

in innate immunity is essential for developing effective diagnostic tools and therapies for infectious

Purpose: It is now known that traumatic injury initiates a complex and dynamic immune response

prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC, immune checkpoint

related toxicity. Immune-related adverse events (irAEs) are a major cause of immune checkpoint inhibitors

Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа, a promising direction is NF1 therapy with STAT3 inhibitors and immune checkpoint inhibitors

, immune system development, and the corresponding response to therapy. © 2023 by the authors.

and an immunomodulator Imunofan to optimize therapy of the convalescent period of haemorrhagic fever with renal syndrome

СОВРЕМЕННЫЕ ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ ТЯЖЕЛЫХ ФОРМ МЕНИНГОКОККОВОЙ ИНФЕКЦИИ В РЕСПУБЛИКЕ БАШКОРТОСТАНTHE ROLE OF CYTOKINS IN THE IMMUNE HEMORRHAGIC FEVER WITH RENAL SYNDROME